Pages that link to "Q33932609"
Jump to navigation
Jump to search
The following pages link to The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery (Q33932609):
Displaying 50 items.
- Recent advances in metabolic and bariatric surgery (Q26745203) (← links)
- Mechanisms of surgical control of type 2 diabetes: GLP-1 is key factor (Q26745621) (← links)
- Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity (Q26828547) (← links)
- Benefits of short-term dietary restriction in mammals (Q26830788) (← links)
- Metabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literature (Q27010589) (← links)
- A gut feeling to cure diabetes: potential mechanisms of diabetes remission after bariatric surgery (Q28080484) (← links)
- Could the mechanisms of bariatric surgery hold the key for novel therapies? report from a Pennington Scientific Symposium. (Q33723458) (← links)
- The sum of many parts: potential mechanisms for improvement in glucose homeostasis after bariatric surgery (Q33761529) (← links)
- Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass (Q33799812) (← links)
- Cardiometabolic Plasticity in Response to a Short-Term Diet and Exercise Intervention in Young Hispanic and NonHispanic White Adults (Q33834006) (← links)
- Does gastric bypass surgery change body weight set point? (Q33838159) (← links)
- Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes. (Q33916655) (← links)
- Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers (Q34024108) (← links)
- Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. (Q34191173) (← links)
- Bariatric surgery for type 2 diabetes (Q34280152) (← links)
- Gastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus (Q34366918) (← links)
- Increased vaspin levels are associated with beneficial metabolic outcome pre- and post-bariatric surgery (Q34395563) (← links)
- Metabolic bariatric surgery and type 2 diabetes mellitus: an endocrinologist's perspective (Q34471033) (← links)
- Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action (Q34503739) (← links)
- Harnessing the beneficial properties of adipogenic microbes for improving human health. (Q34714843) (← links)
- Gastric bypass surgery is associated with near-normal insulin suppression of lipolysis in nondiabetic individuals (Q34783509) (← links)
- Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery (Q34979966) (← links)
- Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetes (Q35165204) (← links)
- GLP-1 plays a limited role in improved glycemia shortly after Roux-en-Y gastric bypass: a comparison with intensive lifestyle modification (Q35360690) (← links)
- Mechanisms Responsible for Excess Weight Loss after Bariatric Surgery (Q35529693) (← links)
- Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission (Q35577707) (← links)
- Gastrointestinal hormones and bariatric surgery-induced weight loss (Q35581251) (← links)
- Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after Roux-en-Y gastric bypass surgery in patients randomized to omentectomy (Q35620195) (← links)
- Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery. (Q35703158) (← links)
- Six and 12 Weeks of Caloric Restriction Increases β Cell Function and Lowers Fasting and Postprandial Glucose Concentrations in People with Type 2 Diabetes (Q35992525) (← links)
- Leptin deficient ob/ob mice and diet-induced obese mice responded differently to Roux-en-Y bypass surgery (Q36028309) (← links)
- Physiology of Weight Loss Surgery (Q36055375) (← links)
- Tryptophan Predicts the Risk for Future Type 2 Diabetes (Q36123681) (← links)
- Bariatric surgery and type 2 diabetes: are there weight loss-independent therapeutic effects of upper gastrointestinal bypass? (Q36163431) (← links)
- Acylation stimulating protein reduction precedes insulin sensitization after BPD-DS bariatric surgery in severely obese women (Q36203380) (← links)
- Roux-en-Y Gastric Bypass Acutely Decreases Protein Carbonylation and Increases Expression of Mitochondrial Biogenesis Genes in Subcutaneous Adipose Tissue (Q36288439) (← links)
- Effects of bariatric surgery on glucose homeostasis and type 2 diabetes (Q36292243) (← links)
- Metabolic improvements following Roux-en-Y surgery assessed by solid meal test in subjects with short duration type 2 diabetes (Q36298931) (← links)
- Comparison of Bariatric Surgical Procedures for Diabetes Remission: Efficacy and Mechanisms (Q36479829) (← links)
- Improved insulin sensitivity after gastric bypass correlates with decreased total body fat, but not with changes in free fatty acids (Q36659386) (← links)
- Appetite and body weight regulation after bariatric surgery (Q36669384) (← links)
- Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes. (Q36747962) (← links)
- Cure of Type 2 Diabetes by Metabolic Surgery? A Critical Analysis of the Evidence in 2010 (Q36790184) (← links)
- Type 2 Diabetes Remission Rates After Laparoscopic Gastric Bypass and Gastric Banding: Results of the Longitudinal Assessment of Bariatric Surgery Study (Q37025587) (← links)
- Rapid improvement in diabetes after gastric bypass surgery: is it the diet or surgery? (Q37106477) (← links)
- Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and β-cell Function in type 2 diabetic patients (Q37110587) (← links)
- Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes. (Q37110621) (← links)
- Type 2 diabetes, bariatric surgery and the risk of subsequent gestational diabetes (Q37185981) (← links)
- Roux-en-Y gastric bypass surgery is effective in fibroblast growth factor-21 deficient mice. (Q37278829) (← links)
- β-Cell function improvements in grade I/II obese subjects with type 2 diabetes 1 month after biliopancreatic diversion: results from modeling analyses of oral glucose tolerance tests and hyperglycemic clamp studies (Q37331230) (← links)